WuXi Vaccines (Cayman) Inc. announced private placement of shares for gross proceeds of $136,000,000 on May 13, 2021. The transaction will include participation from existing investors Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718) for up to $40,500,000 to retain its 30% stake and WuXi Biologics (Cayman) Inc. (SEHK:2269) for up to $95,500,000 to retain its 70% stake. The transaction was approved by the 26th meeting of the 3rd directorate of Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718).

The transaction is subject to approval of shareholders of Shanghai Hile Bio-Technology Co., Ltd. (SHSE:603718).